About SSI Strategy
SSI Strategy is a company based in Parsippany Troy Hills (United States) founded in 2010 was acquired by Clinigen in September 2025. SSI Strategy has completed 3 acquisitions, including Fiore Healthcare Advisors, NDA Group and Scientific Advantage. SSI Strategy offers products and services including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance. SSI Strategy operates in a competitive market with competitors including Fusion Antibodies, Health Decisions, August Research, Phastar and ProductLife Group, among others.
- Headquarter Parsippany Troy Hills, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ssi Strategy Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Clinigen
& 2 more
-
Employee Count
Not available
-
Investments & Acquisitions
Fiore Healthcare Advisors
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SSI Strategy
SSI Strategy offers a comprehensive portfolio of products and services, including Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance.
Ensures scientific integrity and stakeholder engagement
Innovates therapies through patient-centric approaches
Provides leadership for trial execution and excellence
Offers strategies for successful drug approvals
Accelerates success via strategic oversight
People of SSI Strategy
Unlock access to complete
Funding Insights of SSI Strategy
Investors in SSI Strategy
SSI Strategy has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Clinigen, Amulet Capital and HGGC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Amulet Capital is focused on healthcare private equity investments.
|
Locked | Locked | Locked | |
|
Private equity firm focused on middle market investments.
|
Locked | Locked | Locked | |
|
Specialty medicines are supplied via clinical trials and access programs.
|
Locked | Locked | Locked |
Investor details for SSI Strategy
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SSI Strategy
SSI Strategy has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Fiore Healthcare Advisors, NDA Group and Scientific Advantage.
Investment portfolio details for SSI Strategy
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provider of data safety review, auditing, and other consulting services
|
Locked | Locked | 2014 | Locked | |
|
Medical affairs solutions including training and compliance services are offered.
|
Locked | Locked | 2002 | Locked | |
|
Regulatory, pharmacovigilance and quality assurance services
|
Locked | Locked | 1997 | Locked |
Complete acquisition details for SSI Strategy
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - SSI Strategy
Detailed financials for SSI Strategy
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ssi Strategy Comparisons
Peer comparison for SSI Strategy
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SSI Strategy
SSI Strategy operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Fusion Antibodies, Health Decisions, August Research, Phastar and ProductLife Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Company offering a range of services in antibody production, development, characterization and optimization right from discovery to commercialization
|
|
| Locked | Locked | Locked |
CRO focused on clinical trial services for data management, monitoring and biostatistics
|
|
| Locked | Locked | Locked |
Clinical trial services are offered in Central and Eastern Europe.
|
|
| Locked | Locked | Locked |
Statistical consulting and data management for clinical trials are offered.
|
|
| Locked | Locked | Locked |
Regulatory and pharmacovigilance support is provided for product lifecycles.
|
Detailed competitors of SSI Strategy
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ssi Strategy
Complete news archive for SSI Strategy
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SSI Strategy
SSI Strategy was founded in 2010 and raised its 1st funding round 10 years after it was founded.
SSI Strategy is headquartered in Parsippany Troy Hills, United States. It is registered at Parsippany Troy Hills, New Jersey, United States.
SSI Strategy was founded in 2010 and is based in Parsippany Troy Hills, United States. Services in medical affairs, pharmacovigilance, and clinical development are provided to emerging, mid-size, and global pharmaceutical and biotech companies. Offerings include global medical affairs transformation, post-merger integration, launch preparation, pharmacovigilance system enhancements, medical planning, tactic prioritization, and emerging markets support. Scientific Advantage was acquired in October 2016 to broaden medical affairs capabilities.
SSI Strategy's top competitors include Fusion Antibodies, ProductLife Group and Health Decisions.
SSI Strategy offers Strategic Medical Office, Translational & Clinical Development, Clinical Operations, Regulatory Affairs, and Quality & Compliance.
SSI Strategy has made 3 acquisitions, including Fiore Healthcare Advisors, NDA Group, and Scientific Advantage.
SSI Strategy has 3 investors. Key investors include Clinigen, Amulet Capital, and HGGC.